Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities

McLaughlin, V.V., Sitbon, O., Chin, K.M. et al. (11 more authors) (2024) Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities. European Journal of Heart Failure, 26 (11). pp. 2379-2391. ISSN 1388-9842

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • McLaughlin, V.V.
  • Sitbon, O.
  • Chin, K.M.
  • Galiè, N.
  • Hoeper, M.M.
  • Kiely, D.G. ORCID logo https://orcid.org/0000-0003-0184-6502
  • MacDonald, G.
  • Martin, N.
  • Mathai, S.C.
  • Peacock, A.
  • Tawakol, A.
  • Torbicki, A.
  • Noordegraaf, A.V.
  • Rosenkranz, S.
Copyright, Publisher and Additional Information:

© 2024 Actelion Pharmaceuticals Ltd. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Keywords: Pulmonary arterial hypertension; Risk stratification; Cardiac comorbidities; Macitentan; Tadalafil; Initial double combination therapy
Dates:
  • Published: November 2024
  • Published (online): 5 July 2024
  • Accepted: 15 May 2024
  • Submitted: 26 January 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 08 Jul 2024 14:00
Last Modified: 12 Mar 2025 12:21
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1002/ejhf.3319
Open Archives Initiative ID (OAI ID):

Export

Statistics